Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M Bavarian Biotech Report 2011/2012 (7MB) - Bio M

13.07.2015 Views

SERVIER Deutschland GmbHPHARMA & CHEMICAL INDUSTRYContact:Horst StemmerElsenheimer Str. 53D-80687 MünchenPhone: +49 (0) 89 57095-01Fax: +49 (0) 89 57095-126E-Mail: info@de.netgrs.comInternet: www.servier.deKeywords: Pharma Industry Drug Development, Clinical Research, Bone /Joint Diseases, Cardiovascular Diseases, CNS, DiabeticsFollowing its international success, SERVIER Deutschland GmbH has establishedan independent branch in Munich since 1996. SERVIER is one of thevery dynamic pharmaceutical companies in Germany, experiencing agrowth-rate in double figures on average. The reason for this is not only theapproved and merchandised drugs but also new, innovative products. Thesuccess of the new drugs is supported by the SERVIER Forschung undPharma-Entwicklung GmbH (also in Munich), which manages many differentprojects throughout the German-speaking region.Contact:Dr. Udo SticherEschenstr. 5D-82024 TaufkirchenPhone: +49 (0) 89 6513-1504Fax: +49 (0) 89 6513-1399E-Mail: udo.sticher@sial.comInternet: www.sigma-aldrich.comSigma-Aldrich Chemie GmbHBIOTECH DEVICES & REAGENTSKeywords: Proteomics, Antibody, Genomics, CNS, Small Molecules, KnockOut, PCRSigma-Aldrich is a leading Life Science and High Technology company. Ourbiochemical and organic chemical products and kits are used in scientificand genomic research, biotechnology, pharmaceutical development, the diagnosisof disease and as key components in pharmaceutical and other hightechnology manufacturing. We have customers in life science companies,university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 36 countries and has over 7,600 employees providingexcellent service worldwide.SiNatur GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSContact:Dr. Franz KerekAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 856625-55Fax: +49 (0) 89 856625-56E-Mail: kerek@sinatur.netInternet: www.sinatur.netKeywords: Diabetics, Metabolic DiseasesSiNatur owns the patent rights for the structure, preparation and medicinalapplications Sub-Nano-Silicic Acid (SNSA). This recently discovered SNSA isthe first biologically active form of silicic acid and of silicon generally. Thesubstance is a potent inhibitor of P-type ATPases and of certain Protein-Phosphatases with IC50 in the nanomolar range.Due to the ubiquitous presence of Si in living organisms the discovery ofthe first biological active form of this element will have a broad scientificand practical impact.SiNatur is developing medicinal applications of SNSA first of all in the therapyof diabetes and of gastric hyperacidity.110

SIRION BIOTECH GmbHBIOTECH DEVICES & REAGENTSKeywords: Gene Transfer, Drug Development, Drug Delivery, Knock Out, RNAi& AntisenseSIRION BIOTECH GmbH is a biotech company that produces geneticallymodified cells and is a technology provider in the area of viral vectorsystems. The company founded in 2006 is located in the Innovations- undGründerzentrum Biotechnologie IZB in Martinsried near Munich. The expertin RNAi technology offers a wide range of more than 100 products andservices. Using state-of-the art techniques and assay systems the companyoffers reliable lead-through service projects in target validation, screeningand drug discovery. With its strong expertise in primary cell handlingisolation, and cell line generation SIRION BIOTECH serves as a partner foroptimized drug development for pharamceutical and biotech companies.Contact:Dr. Christian ThirionAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 700961-999Fax: +49 (0) 89 700961-998E-Mail: info@sirion-biotech.deInternet: www.sirion-biotech.comSMARTEC IngenieurBüroBIOTECH DEVICES & REAGENTS, MEDTECHKeywords: Devices, Automation, Chip / Array Technology, PCR, TissueEngineering / Cell CultureSmartec IngenieurBüro is your competent partner for individual systemapproaches and instrument development in the biological laboratory.Smartec IngenieurBüro convinces with know-how within the ranges biotechnology,analytics, genetic engineering, micro technology as well as microfluidic. Smartec IngenieurBüro solves tasks of instrumentation for molecularand immunological process engineering. Smartec IngenieurBüro supportsyou from the idea to all stages of the product. Smartec IngenieurBüro offerscomplete solutions, consisting of mechanics, optics, electronics, as well asfirm- and software of a hand. Smartec IngenieurBüro consists of engineersand physicists which are predominantly settled in the ranges Research andDevelopment (R&D) of bioanalytic systems.Contact:Dipl. Ing. Ulrich SchubertAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 854665-13Fax: +49 (0) 89 854665-15E-Mail: ulrichschubert@smartecbio.deInternet: www.smartecbio.deSpheroTec GmbHBIOTECH PRECLINICAL SERVICESKeywords: Drug Development, Oncology, Tissue Engineering / Cell CultureSpherotec is a biotech company using 3D cell-culture systems that havesimilar properties to microtumors in cancer patients. On this basis,Spherotec offers pharmaceutical and biotech companies the opportunity toconduct functional tests of drug candidates for oncology in close to realconditions. This permits the early identification of promising substances andgives a broad profile of the effects of substances. The process also allowsthe definition of the kinds of tumors for which a substance or a combinationof substances has the best clinical efficacy.Contact:Dr. Ilona FunkeAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 5404134-0Fax: +49 (0) 89 5404134-20E-Mail: info@spherotec.comInternet: www.spherotec.com111

SIRION BIOTECH GmbHBIOTECH DEVICES & REAGENTSKeywords: Gene Transfer, Drug Development, Drug Delivery, Knock Out, RNAi& AntisenseSIRION BIOTECH GmbH is a biotech company that produces geneticallymodified cells and is a technology provider in the area of viral vectorsystems. The company founded in 2006 is located in the Innovations- undGründerzentrum <strong><strong>Bio</strong>tech</strong>nologie IZB in Martinsried near Munich. The expertin RNAi technology offers a wide range of more than 100 products andservices. Using state-of-the art techniques and assay systems the companyoffers reliable lead-through service projects in target validation, screeningand drug discovery. With its strong expertise in primary cell handlingisolation, and cell line generation SIRION BIOTECH serves as a partner foroptimized drug development for pharamceutical and biotech companies.Contact:Dr. Christian ThirionAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 700961-999Fax: +49 (0) 89 700961-998E-Mail: info@sirion-biotech.deInternet: www.sirion-biotech.comSMARTEC IngenieurBüroBIOTECH DEVICES & REAGENTS, MEDTECHKeywords: Devices, Automation, Chip / Array Technology, PCR, TissueEngineering / Cell CultureSmartec IngenieurBüro is your competent partner for individual systemapproaches and instrument development in the biological laboratory.Smartec IngenieurBüro convinces with know-how within the ranges biotechnology,analytics, genetic engineering, micro technology as well as microfluidic. Smartec IngenieurBüro solves tasks of instrumentation for molecularand immunological process engineering. Smartec IngenieurBüro supportsyou from the idea to all stages of the product. Smartec IngenieurBüro offerscomplete solutions, consisting of mechanics, optics, electronics, as well asfirm- and software of a hand. Smartec IngenieurBüro consists of engineersand physicists which are predominantly settled in the ranges Research andDevelopment (R&D) of bioanalytic systems.Contact:Dipl. Ing. Ulrich SchubertAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 854665-13Fax: +49 (0) 89 854665-15E-Mail: ulrichschubert@smartecbio.deInternet: www.smartecbio.deSpheroTec GmbHBIOTECH PRECLINICAL SERVICESKeywords: Drug Development, Oncology, Tissue Engineering / Cell CultureSpherotec is a biotech company using 3D cell-culture systems that havesimilar properties to microtumors in cancer patients. On this basis,Spherotec offers pharmaceutical and biotech companies the opportunity toconduct functional tests of drug candidates for oncology in close to realconditions. This permits the early identification of promising substances andgives a broad profile of the effects of substances. The process also allowsthe definition of the kinds of tumors for which a substance or a combinationof substances has the best clinical efficacy.Contact:Dr. Ilona FunkeAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 5404134-0Fax: +49 (0) 89 5404134-20E-Mail: info@spherotec.comInternet: www.spherotec.com111

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!